CC
BIIB icon

ClearArc Capital’s Biogen BIIB Stock Holding History

ClearArc Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$499K Sell
1,683
-837
-33% -$232K 0.19% 133
2019
Q3 		$587K Sell
2,520
-114
-4% -$26.5K 0.17% 152
2019
Q2 		$616K Sell
2,634
-396
-13% -$91.4K 0.18% 135
2019
Q1 		$716K Sell
3,030
-165
-5% -$52K 0.19% 121
2018
Q4 		$961K Sell
3,195
-1,431
-31% -$457K 0.29% 82
2018
Q3 		$1.63M Sell
4,626
-178
-4% -$61.3K 0.21% 107
2018
Q2 		$1.39M Buy
4,804
+5
+0.1% +$1.41K 0.2% 117
2018
Q1 		$1.31M Buy
4,799
+12
+0.3% +$3.73K 0.2% 120
2017
Q4 		$1.52M Sell
4,787
-9
-0.2% -$2.89K 0.21% 113
2017
Q3 		$1.5M Sell
4,796
-65
-1% -$19.2K 0.23% 105
2017
Q2 		$1.32M Sell
4,861
-36
-0.7% -$9.52K 0.21% 115
2017
Q1 		$1.34M Sell
4,897
-401
-8% -$113K 0.22% 112
2016
Q4 		$1.5M Sell
5,298
-67
-1% -$19.9K 0.27% 97
2016
Q3 		$1.68M Buy
5,365
+28
+0.5% +$8.29K 0.32% 80
2016
Q2 		$1.29M Buy
5,337
+4
+0.1% +$1.05K 0.25% 101
2016
Q1 		$1.39M Sell
5,333
-137
-3% -$36.2K 0.29% 85
2015
Q4 		$1.68M Sell
5,470
-237
-4% -$68.1K 0.35% 75
2015
Q3 		$1.67M Sell
5,707
-117
-2% -$38.6K 0.35% 74
2015
Q2 		$2.35M Buy
5,824
+733
+14% +$294K 0.43% 55
2015
Q1 		$2.15M Buy
5,091
+65
+1% +$25.6K 0.44% 57
2014
Q4 		$1.71M Buy
5,026
+101
+2% +$32.7K 0.35% 83
2014
Q3 		$1.63M Buy
4,925
+78
+2% +$25.7K 0.37% 74
2014
Q2 		$1.53M Buy
4,847
+99
+2% +$29.8K 0.35% 84
2014
Q1 		$1.45M Buy
4,748
+311
+7% +$98.7K 0.36% 76
2013
Q4 		$1.24M Buy
4,437
+28
+0.6% +$7.24K 0.32% 90
2013
Q3 		$1.06M Sell
4,409
-1,113
-20% -$249K 0.3% 98
2013
Q2 		$1.19M Buy
+5,522
New +$1.18M 0.32% 93

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ClearArc Capital's BIIB Position: Q4 2019 in Review

ClearArc Capital reduced its Biogen (BIIB) stake by 33% in Q4 2019, selling an estimated $232K and leaving 1,683 shares worth $499K. The position accounts for 0.19% of the portfolio, ranked #133.

ClearArc Capital first reported a position in BIIB in Q2 2013 and has held it in 27 quarters since. The position peaked at $2.35M in Q2 2015. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • ClearArc Capital held 1,683 shares of Biogen worth $499K as of Q4 2019.
  • ClearArc Capital sold 837 Biogen shares in Q4 2019, an estimated $232K.
  • Biogen made up 0.19% of ClearArc Capital's portfolio in Q4 2019, its #133 holding.
  • ClearArc Capital first reported a position in Biogen in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's Biogen position peaked at $2.35M in Q2 2015.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.